Features Partner Sites Information LinkXpress
Sign In
Advertise with Us


11 Nov 2017 - 15 Nov 2017
13 Nov 2017 - 16 Nov 2017

Regeneration of Heart Tissue Induced by Cardiac Stem Cells

By BiotechDaily International staff writers
Posted on 09 Feb 2017
Print article
Image: Heart cells growing in rectangular, box-like scaffold made with three-dimensional printing (Photo courtesy of the University of Alabama).
Image: Heart cells growing in rectangular, box-like scaffold made with three-dimensional printing (Photo courtesy of the University of Alabama).
Nanoscale three-dimensional printing was used to create a scaffold for the growth of cardiovascular tissue that could be transplanted into a damaged heart following a heart attack.

The heart cannot normally regenerate muscle tissue after a heart attack has killed part of the muscle wall. In order to spur the damaged heart into regenerating new tissue, investigators at the University of Alabama and the University of Minnesota used multiphoton-excited, three-dimensional printing (MPE-3DP) to generate a native-like, extracellular matrix (ECM) scaffold with submicron resolution.

This novel scaffolding was seeded with approximately 50,000 human, iPSC (induced pluripotent stem cell)-derived cardiomyocytes (CMs), smooth muscle cells (SMCs), and endothelial cells (ECs) in a 2:1:1 ratio to generate the hCMP (human, iPSC-derived cardiac muscle patch). The patch began generating calcium transients and beating synchronously within one day of seeding; the speeds of contraction and relaxation and the peak amplitudes of the calcium transients increased significantly over the next seven days.

The investigators reported in the January 9, 2017, online edition of the journal Circulation Research that when tested in mice with surgically induced myocardial infarction (MI), measurements of cardiac function, infarct size, apoptosis, both vascular and arteriole density, and cell proliferation at week four after treatment were significantly better in animals treated with the hCMPs than in animals treated with cell-free scaffolds.

The authors concluded that, “Thus, the hiPSC-derived cardiac muscle patches produced for this report may represent an important step toward the clinical use of three-dimensional-printing technology. To our knowledge, this is the first time modulated raster scanning has ever been successfully used to control the fabrication of a tissue-engineered scaffold, and consequently, our results are particularly relevant for applications that require the fibrillar and mesh-like structures present in cardiac tissue.”

Print article



view channel

Collaborative Agreement to Aid in Setting Guidelines for Evaluating Potential Ebola Therapy

Cooperation between an Israeli biopharmaceutical company and medical branches of the US government is designed to set ground rules for continued evaluation of an experimental therapy for Ebola virus disease. RedHill Biopharma Ltd. (Tel Aviv, Israel), a biopharmaceutical company primarily focused on development and c... Read more
Copyright © 2000-2017 Globetech Media. All rights reserved.